Peregrine Pharmaceuticals Inc
|
14272 Franklin Avenue
Suite 100
Tustin, CA 92780-7017
United States |
| Tel: |
1/714-508-6000 |
| URL: |
http://www.peregrineinc.com/ |
|
 |
| Primary Symbols & Exchanges: |
| PPHM - NASDAQ |
| - Berlin-Bremen Stock Exchange |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activities are the research, development, manufacture and commercialization of monoclonal antibody-based targeted therapeutics for the treatment of solid cancers and viral infections. It operates in two segments; Contract Manufacturing and Licensing.TheContract Manufacturing focuses on research and development of monoclonal antibody-based therapeutics and Licensing focuses on providing bio-manufacturing services for Peregrine and outside customers on a fee-for-services basis.The Group currently advancing three separate clinical trial programs for the treatment of cancer and chronic hepatitis C virus (HCV) infection. It also conducts internal research and collaborations with researchers at academic institutions to extend the product pipeline to include new therapeutics and therapeutic adjuvants. The Group operates in the United States. On 28,Aug, 2006, the Group established Peregrine (Beijing) Pharmaceutical Technology Ltd in China. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Peregrine Pharmaceuticals Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
